- Vouliez-vous dire
- carcinoma
Résultats de la recherche - 4 results
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.
adenocarcinoma in situ associated with HPV16 /18 infection in young women who were not initially infected with hrHPV or HPV16 /18. Vaccine efficacy was lower when all women regardless of HPV DNA status at ...
Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections.
intraepithelial neoplasia (CIN), 32 CIN1, 34 CIN2, 14 CIN3 and one adenocarcinoma in situ. Hr- HPV testing detected all CIN3 + cases on the clinician-taken or Evalyn self-samples (14/14) and 93% of them on the ...
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.
10(5) (23·2-53·5), respectively, in the control arm. Rate ratios did not differ by cancer stage, but were lower for adenocarcinoma (0·31, 0·14-0·69) than for squamous-cell carcinoma (0·78, 0·49-1·25). The ...
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
re-infection, against cervical cancer and its precursors (high-grade CIN (grade 2 or grade 3), adenocarcinoma in situ) in women previously not exposed to HPV infection (negative at enrolment for both HPV DNA and ...